AiTan (rivoceranib) - Elevar Therapeutics
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Analysis of a case of immune-related pancreatitis induced by anti-PD-1 antibody therapy for gastric cancer: A case report. (PubMed, Medicine (Baltimore)) - Oct 10, 2026 - "This case highlights that immune-related pancreatitis may present with only mild abdominal symptoms despite marked pancreatic enzyme elevation during immune checkpoint inhibitor therapy. Clinicians should maintain a high index of suspicion for pancreatic immune-related adverse events, even in the absence of typical imaging findings, and systematically exclude alternative causes to ensure timely and appropriate management." 
Journal • Dyslipidemia • Gastric Cancer • Hepatology • Hypertriglyceridemia • Oncology • Pain • Pancreatitis • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42854075
 
Fengyun Zhang; Wenhua Xiao
 
Oct 10, 2026
 
Prev Next